Green Thumb: The 'Trump Rescheduling Moment' Is Here
Green Thumb Industries is rated a 'Buy,' driven by GAAP profitability, a strong balance sheet, and potential regulatory catalysts. GTBIF stands to benefit significantly if cannabis is rescheduled, potentially normalizing tax rates and boosting net income from $31 million to $106 million YTD. The company's conservative capital allocation, low leverage, and management discipline differentiate GTBIF amid sector volatility and persistent price compression.


















